Francesca B Aiello

Publications (13)46.89 Total impact

• Article: Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients.

  Francesca B Aiello, Lucrezia Furian, Mila Della Barbera, Stefano Marino, Michela Seveso, Massimo Cardillo, Elisa S Pierobon, Emanuele Cozzi, Paolo Rigotti, Marialuisa Valente
  [show abstract] [hide abstract]
  ABSTRACT: In acute rejection after renal transplant, glomerulitis is characterized by mononuclear cells in glomerular capillaries and endothelial cell enlargement. In association with C4d deposition in peritubular capillaries, glomerulitis is a feature of acute antibody-mediated rejection. Prognosis in C4d(+) rejection is poorer than in C4d(-) rejection. We measured the glomerular endothelial cell area in C4d(+) and C4d(-) acute rejections by morphometry. In 90 acute rejection biopsies, glomerulitis was present in 36 cases (group G) and absent in 54 (group G0). In biopsies without rejections and in C4d(-) biopsies of group G0, glomerular endothelial cell area was not significantly different. In C4d(-) and C4d(+) biopsies of group G, the area in inflamed glomeruli was greater than that in C4d(-) biopsies of group G0 (P < .02 and P < .006, respectively). In C4d(+) biopsies of group G0, it was, unexpectedly, greater than in C4d(-) biopsies of group G (P < .01). Circulating posttransplant anti-human leukocyte antigen class I and class II antibodies correlated with increased endothelial cell area (P < .02). Glomerulitis was associated with diffuse C4d deposition (odds ratio [OR], 4.27; P < .004); C4d deposition was associated with steroid resistance (OR, 4.97; P < .002). Only in C4d(+) rejections did the presence of glomerulitis increase this association (OR, 9.17; P < .02). In conclusion, we quantified an increase of endothelial cell area in glomerulitis of C4d(+) and C4d(-) acute rejections (group G). An increase of this area in C4d(+) biopsies without glomerulitis (group G0) suggests complement-mediated damage in the absence of mononuclear cell margination.
  Human pathology 05/2012; · 3.03 Impact Factor
• Article: Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells.

  Roberta Zappacosta, Francesca B Aiello, Tommaso D'Antuono, Antonio D Procopio, Scott K Durum, Pio Conti, Sandra Rosini
  [show abstract] [hide abstract]
  ABSTRACT: Immunofluorescence is the most frequently utilized technique to analyze protein expression. Fixed immunofluorescent cell suspensions, however, can only be stored for a week. We investigated whether liquid-based cytology could be used to detect antigens in cultured cells after a long storage period. Murine and human cells were fixed in PreservCyt solution, stored for various periods, and then used to perform an automated immunocytochemical analysis. Phosphorylation of the nuclear transcription factor Stat-5 induced by IL-7 was detected up to 4 months after IL-7 stimulation. Simultaneous nuclear positivity for the proliferation index MIB-1 and membrane positivity for the CD30 antigen were evident three months after fixation. Liquid-based cytology thus ensures long-lasting nuclear and membrane antigen immunoreactivity and permits the storage of cells from laborious experiments at room temperature for future analyses.
  Annals of clinical and laboratory science 01/2011; 41(4):353-9. · 0.96 Impact Factor
• Article: IL-7 induces myelopoiesis and erythropoiesis.

  Francesca B Aiello, Jonathan R Keller, Kimberly D Klarmann, Glenn Dranoff, Renata Mazzucchelli, Scott K Durum
  [show abstract] [hide abstract]
  ABSTRACT: IL-7 administration to mice was previously reported to increase the mobilization of progenitor cells from marrow to peripheral sites. We now report that IL-7 increases the number of mature myeloid and monocytic cells in spleen and peripheral blood. This effect required T cells, and we show that IL-7 treatment in vivo induced GM-CSF and IL-3 production by T cells with memory phenotype. However, additional myelopoietic cytokines were shown to be involved because mice deficient in both GM-CSF and IL-3 also responded to IL-7 with increased myelopoiesis. Candidate cytokines included IFN-gamma and Flt3 ligand, which were also produced in response to IL-7. Because IFN-gamma-deficient mice also increased myelopoiesis, it was suggested that IL-7 induced production of redundant myelopoietic cytokines. In support of this hypothesis, we found that the supernatant from IL-7-treated, purified T cells contained myelopoietic activity that required a combination of Abs against GM-CSF, IL-3, and anti-Flt3 ligand to achieve maximum neutralization. IL-7 administration increased the number of splenic erythroid cells in either normal, Rag1 or GM-CSF-IL-3-deficient mice, suggesting that IL-7 might directly act on erythroid progenitors. In support of this theory, we detected a percentage of TER-119(+) erythroid cells that expressed the IL-7Ralpha-chain and common gamma-chain. Bone marrow cells expressing IL-7R and B220 generated erythroid colonies in vitro in response to IL-7, erythropoietin, and stem cell factor. This study demonstrates that IL-7 can promote nonlymphoid hemopoiesis and production of cytokines active in the host defense system in vivo, supporting its possible clinical utility.
  The Journal of Immunology 03/2007; 178(3):1553-63. · 5.79 Impact Factor
• Article: Acute rejection and graft survival in renal transplanted patients with viral diseases.

  Francesca B Aiello, Fiorella Calabrese, Paolo Rigotti, Lucrezia Furian, Stefano Marino, Riccardo Cusinato, Marialuisa Valente
  [show abstract] [hide abstract]
  ABSTRACT: Transplanted patients are susceptible to viral infections; thus, the aim of this study was to evaluate the features of acute rejections and the outcome of the renal graft in transplanted patients with herpes virus diseases. Renal biopsies from 30 renal transplanted patients undergoing early acute rejection (type IA and IB according to the Banff 97 classification) were evaluated. In total, 15 of these patients experienced cytomegalovirus (CMV) or Epstein-Barr virus disease within the first year following transplantation (group I) and 15 patients showed no evidence of viral infection (group II). No significant differences between the groups in terms of age, male/female ratio, living/cadaveric donor ratio, cold ischemia time, HLA A-B matching, pretransplant panel reactive antibody test, occurrence of post-transplant tubular necrosis, plasma levels of cyclosporin A and mean percent increase of serum creatinine at the time of the biopsy were observed. In group I biopsies, the mean number of interstitial plasma cells, as well as the mean number of CD79a-positive cells (B lymphocytes and plasma cells) was significantly higher than in group II (P<0.01 and <0.01, respectively). There was a positive correlation between the number of infections and the number of plasma cells (P<0.05). In transplanted patients, CMV can trigger the formation of anti-endothelial cell antibodies, which have been proposed to play a role in antibody-mediated rejections. We investigated whether a deposition of C4d, a marker of antibody-mediated reactions, was present in renal peritubular capillaries. In group I C4d deposition was found in five cases, while in group II it was not observed (P<0.05). In group I, 7/15 patients developed chronic allograft nephropathy vs 1/15 patients in group II (P<0.05). The estimated 1-, 5- and 8-year cumulative graft survival rates were 80, 66 and 57%, respectively, in group I, while in group II the estimated 8-year cumulative survival rate was 100% (P<0.05). In conclusion, acute rejection biopsies of patients with viral infections displayed plasma cell infiltrates and, in several cases, C4d deposition. Our study suggests a role of B lymphocytes in the pathology of these rejections and confirms the association between viral infections and poor graft survival.
  Modern Pathology 02/2004; 17(2):189-96. · 4.79 Impact Factor
• Source

  Available from: martalive.org

  Article: Gene expression of transforming growth factor beta receptors I and II in non-small-cell lung tumors.

  Antonella Colasante, Francesca B Aiello, Mauro Brunetti, Francesco S di Giovine
  [show abstract] [hide abstract]
  ABSTRACT: Transforming growth factor (TGF)beta inhibits normal epithelial cell proliferation. A decreased expression of TGFbeta receptors (TbetaR) has been associated with loss of TGFbeta sensitivity and enhanced tumor progression in many types of cancer. Although lung cancer is one of the leading causes of cancer death, a comparative analysis of TbetaR mRNA and protein expression in non-small-cell (NSC) lung tumors has not been performed. Lung tumor tissues and control non-lesional lung tissues were obtained from 17 patients undergoing thoracotomy for primary NSC lung tumors in clinical stage II. Each tissue sample was studied for TbetaRI and TbetaRII mRNA and immunoreactive protein expression, using a semi-quantitative reverse transcription-PCR method, and a quantitative immunohistochemistry method, respectively. TbetaRI protein expression was higher in tumors than in controls (p=0.0005) and a similar trend was present at the mRNA level. TbetaRII protein expression was not significantly different between tumors and controls, however an intense peri-nuclear staining for TbetaRII was observed in several tumor cells. TbetaRII mRNA levels were lower in tumors than in controls (p=0.005) and an inverse relation between TbetaRII mRNA and protein expression was detected in tumors (p=0.0013). Our findings suggest an altered function of the TbetaR system in NSC lung cancer.
  Cytokine 01/2004; 24(5):182-9. · 3.02 Impact Factor
• Article: Mumps-associated nephritis mimicking acute rejection in a patient under chronic dialysis treatment because of graft dysfunction.

  Francesca B Aiello, Fiorella Calabrese, Lucrezia Furian, Nicola Baldan, Francesco Marchini, Paolo Rigotti, Marialuisa Valente
  Transplant International 11/2002; 15(9-10):523-4. · 2.92 Impact Factor
• Article: Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells.

  Mauro Brunetti, Nicola Mascetra, Nicola Martelli, Franco O Ranelletti, Piero Musiani, Francesca B Aiello
  [show abstract] [hide abstract]
  ABSTRACT: We have previously demonstrated that interleukin (IL)-10 synergizes with dexamethasone (Dex) in inhibiting proliferation of human T cells, stimulated in an antigen-presenting cell (APC)-dependent manner. Because IL-10 effectively inhibits APC accessory functions, the synergism could have been a result of its effect on APC. We then investigated the effects of Dex and IL-10 on T-cell subpopulations, stimulated in an APC-independent manner. CD4 and CD8 T cells were stimulated with anti-CD3, with or without Dex and IL-10, alone or in combination. Proliferation, glucocorticoid (GC) receptor binding, anti-CD3-induced tyrosine phosphorylation, IL-2 production, and expression of IL-2 receptor alpha, beta, and gamma chains were evaluated. The pharmacologic interactions were analyzed using the isobole method. IL-10 synergized with Dex in inhibiting CD4 but not CD8 T-cell proliferation. The synergism was not associated with modifications of GC receptor number or affinity, nor with modifications of anti-CD3-induced tyrosine phosphorylation. IL-10 synergized with Dex in inhibiting IL-2 production and increased Dex inhibitory effect on the expression of the IL-2 receptor alpha chain, which is up-regulated by CD3 stimulation and IL-2. Only Dex inhibited the beta and gamma chain expression, which, interestingly, is not up-regulated by IL-2. IL-2, as well as IL-7 and IL-15, reversed the effects of IL-10 but not those of Dex. IL-10 synergizes with Dex in inhibiting CD4 T-cell proliferation. Its synergizing effect is mediated by the inhibition of IL-2 production. Dex exerts additional activities, such as the inhibition of beta and gamma chain expression. Therefore, IL-10 could be useful for the enhancement of GC-based immunosuppressive therapies.
  Transplantation 11/2002; 74(8):1152-8. · 4.00 Impact Factor
• Article: Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells1

  Mauro Brunetti, Nicola Mascetra, Nicola Martelli, Franco O. Ranelletti, Piero Musiani, Francesca B. Aiello
  [show abstract] [hide abstract]
  ABSTRACT: Background. We have previously demonstrated that interleukin (IL)-10 synergizes with dexamethasone (Dex) in inhibiting proliferation of human T cells, stimulated in an antigen-presenting cell (APC)-dependent manner. Because IL-10 effectively inhibits APC accessory functions, the synergism could have been a result of its effect on APC. We then investigated the effects of Dex and IL-10 on T-cell subpopulations, stimulated in an APC-independent manner. Methods. CD4+ and CD8+ T cells were stimulated with anti-CD3, with or without Dex and IL-10, alone or in combination. Proliferation, glucocorticoid (GC) receptor binding, anti-CD3-induced tyrosine phosphorylation, IL-2 production, and expression of IL-2 receptor α, β, and γ chains were evaluated. The pharmacologic interactions were analyzed using the isobole method. Results. IL-10 synergized with Dex in inhibiting CD4+ but not CD8+ T-cell proliferation. The synergism was not associated with modifications of GC receptor number or affinity, nor with modifications of anti-CD3-induced tyrosine phosphorylation. IL-10 synergized with Dex in inhibiting IL-2 production and increased Dex inhibitory effect on the expression of the IL-2 receptor α chain, which is up-regulated by CD3 stimulation and IL-2. Only Dex inhibited the β and γ chain expression, which, interestingly, is not up-regulated by IL-2. IL-2, as well as IL-7 and IL-15, reversed the effects of IL-10 but not those of Dex. Conclusions. IL-10 synergizes with Dex in inhibiting CD4+ T-cell proliferation. Its synergizing effect is mediated by the inhibition of IL-2 production. Dex exerts additional activities, such as the inhibition of β and γ chain expression. Therefore, IL-10 could be useful for the enhancement of GC-based immunosuppressive therapies.
  Transplantation 10/2002; 74(8):1152-1158. · 4.00 Impact Factor
• Article: Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis.

  Mauro Brunetti, Nicola Mascetra, Stefano Manarini, Nicola Martelli, Chiara Cerletti, Piero Musiani, Francesca B Aiello, Virgilio Evangelista
  [show abstract] [hide abstract]
  ABSTRACT: The signalling pathways mediating neutrophil spontaneous apoptosis are still largely unknown. We report that the indolocarbazole compound KT5823, a specific inhibitor of cGMP-dependent protein kinases (cGK), dose-dependently inhibited spontaneous apoptosis of neutrophils. At the concentration eliciting the maximum effect (8 microM), it decreased apoptosis from 72.42+/-12.79% to 45.86+/-7.22% (p=0.0002, n=6). Similarly, the isoquinoline sulfonamide compound H89, another cGK inhibitor, prevented neutrophil apoptosis. At the concentration eliciting the maximum effect (20 microM), it decreased apoptosis from 72.42+/-12.79% to 31.84+/-10.70% (p=0.0004, n=6). The maximum effect of KT5823 and H89 was comparable to that of GM-CSF and LPS, respectively. Moreover, YC-1, a soluble guanylate cyclase activator, and 4-([3',4',-(methylenedioxy)benzyl]amino)-6-methoxyquinazoline, a specific phosphodiesterase 5 inhibitor, enhanced neutrophil apoptosis, and their effect was antagonised by KT5823. Taken together, these observations highlight a new role of cGK as important mediators of neutrophil spontaneous apoptosis.
  Biochemical and Biophysical Research Communications 10/2002; 297(3):498-501. · 2.48 Impact Factor
• Article: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential

  Sara Caltagirone, Cosmo Rossi, Andreina Poggi, Franco O. Ranelletti, Pier Giorgio Natali, Mauro Brunetti, Francesca B. Aiello, Mauro Piantelli
  [show abstract] [hide abstract]
  ABSTRACT: Flavonoids are a class of polyphenolic compounds widely distributed in the plant kingdom, which display a variety of biological activities, including chemoprevention and tumor growth inhibition. Our aim was to investigate the effects of several polyphenols on the growth and metastatic potential of B16-BL6 melanoma cells in vivo. Intraperitoneal administration of quercetin, apigenin, (–)-epigallocathechin-3-gallate (EGCG), resveratrol, and the anti-estrogen tamoxifen, at the time of i.m. injection of B16-BL6 cells into syngeneic mice, resulted in a significant, dose-dependent delay of tumor growth, without toxicity. The relative descending order of potency was EGCG > apigenin = quercetin = tamoxifen > resveratrol > control. Furthermore, polyphenols significantly potentiated the inhibitory effect of a non-toxic dose of cisplatin. When tested for the ability to inhibit lung colonization, quercetin, apigenin, and tamoxifen (but not EGCG or resveratrol) significantly decreased the number of B16-BL6 colonies in the lungs in a dose-dependent manner, with quercetin and apigenin being more effective than tamoxifen. Interestingly, quercetin, apigenin, and tamoxifen (but not EGCG or resveratrol) significantly decreased the invasion of B16-BL6 cells in vitro, with quercetin and apigenin being more effective than tamoxifen. This suggests that anti-invasive activity is one of the mechanisms underlying inhibition of lung colonization by quercetin and apigenin. In conclusion, quercetin and apigenin inhibit melanoma growth and invasive and metastatic potential; therefore, they may constitute a valuable tool in the combination therapy of metastatic melanoma. Int. J. Cancer 87:595–600, 2000. © 2000 Wiley-Liss, Inc.
  International Journal of Cancer 08/2000; 87(4):595 - 600. · 5.44 Impact Factor
• Article: Phenotypical characteristics and proliferative capabilities of thymocyte subsets in human thymoma

  Piero Musiani, Nicola Maggiano, Francesca B. Aiello, Luigi M. Larocca, Mauro Piantelli
  [show abstract] [hide abstract]
  ABSTRACT: The phenotypical and functional characteristics of the lymphoid component present in ten human thymomas have been analyzed. Thymomas were classified according to the predominant epithelial cell type present in the neoplastic gland. In thymomas of the cortical type a large proportion, clearly higher than that present in mixed thymomas of T6-positive lymphocytes was present. This T6 subset did not proliferate to mitogen but contained almost all thymocytes able to spontaneously proliferate. Higher proportions of T3-positive cells were found in mixed types of thymomas than in cortical-type tumors. This T3+ subset responded to mitogen stimulation and constituted the more mature intrathymic pool. Surprisingly we identified in thymomas a further subset, lacking the cortical and medullary markers T6 and T3, capable of responding to mitogen. The occurrence of higher proliferative responses to phytohemagglutinin (PHA) in the unfractionated population of cells from mixed thymomas than in the cells of cortical thymomas was judged to be attributable to the relatively higher content of both T3-positive and T3, T6-negative thymocytes in the former. Unlike T6+ thymocytes. T3−T6− as well as T3+ cells were practically devoid of spontaneous proliferative capacity. The expansion of the intrathymic lymphoid component in human thymomas should then be considered to be attributable to the “spontaneous” proliferative capacity of the T6+ cell pool. In this respect, cortical thymomas not only contained more T6+ cells than the mixed type but also exhibited a higher lymphocyte/epithelial cell ratio and more frequent mitotic figures.
  Clinical Immunology and Immunopathology 40(3):385-392.
• Article: Cell biology of IL-7, a key lymphotrophin.

  Qiong Jiang, Wen Qing Li, Francesca B Aiello, Renata Mazzucchelli, Benyam Asefa, Annette R Khaled, Scott K Durum
  [show abstract] [hide abstract]
  ABSTRACT: IL-7 is essential for the development and survival of T lymphocytes. This review is primarily from the perspective of the cell biology of the responding T cell. Beginning with IL-7 receptor structure and regulation, the major signaling pathways appear to be via PI3K and Stat5, although the requirement for either has yet to be verified by published knockout experiments. The proliferation pathway induced by IL-7 differs from conventional growth factors and is primarily through posttranslational regulation of p27, a Cdk inhibitor, and Cdc25a, a Cdk-activating phosphatase. The survival function of IL-7 is largely through maintaining a favorable balance of bcl-2 family members including Bcl-2 itself and Mcl-1 on the positive side, and Bax, Bad and Bim on the negative side. There are also some remarkable metabolic effects of IL-7 withdrawal. Studies of IL-7 receptor signaling have yet to turn up unique pathways, despite the unique requirement for IL-7 in T cell biology. There remain significant questions regarding IL-7 production and the major producing cells have yet to be fully characterized.
  Cytokine & Growth Factor Reviews 16(4-5):513-33. · 7.81 Impact Factor
• Source

  Available from: landesbioscience.com

  Article: Interleukin-7 induces MUC1.

  Scott K Durum, Francesca B Aiello
  Cancer biology & therapy 2(2):194-5. · 2.64 Impact Factor